Literature DB >> 10918596

p53-dependent apoptosis is regulated by a C-terminally alternatively spliced form of murine p53.

N Almog1, N Goldfinger, V Rotter.   

Abstract

It is now well accepted that the p53 C-terminus plays a central role in controlling the activity of the wild-type molecule. In our previous studies, we observed that a C-terminally altered p53 protein (p53AS), generated by an alternative spliced p53 mRNA, induces an attenuated p53-dependent apoptosis, compared to that induced by the regularly spliced form (p53RS). In the present study we analysed the interrelationships between these two physiological variants of wild-type p53, and found that in cells co-expressing both forms, in contrast to the expected additive effect on the induction of apoptosis, p53AS inhibits apoptosis induced by p53RS. This inhibitory effect is specific for p53-dependent apoptosis and was not evident in a p53-independent apoptotic pathway induced by growth factor deprivation. Furthermore, the expression of p53AS in transiently transfected cells caused both inhibition of apoptosis and inhibition of the p53RS-dependent transactivation of a number of p53 target genes. These results suggest that expression of an alternatively spliced p53 form may serve as an additional level in controlling the complexity of p53 function by the C-terminal domain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918596     DOI: 10.1038/sj.onc.1203673

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  p53 isoforms can regulate p53 transcriptional activity.

Authors:  Jean-Christophe Bourdon; Kenneth Fernandes; Fiona Murray-Zmijewski; Geng Liu; Alexandra Diot; Dimitris P Xirodimas; Mark K Saville; David P Lane
Journal:  Genes Dev       Date:  2005-08-30       Impact factor: 11.361

2.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

Review 3.  p53 Isoforms: Key Regulators of the Cell Fate Decision.

Authors:  Sebastien M Joruiz; Jean-Christophe Bourdon
Journal:  Cold Spring Harb Perspect Med       Date:  2016-08-01       Impact factor: 6.915

Review 4.  Having it both ways: transcription factors that bind DNA and RNA.

Authors:  Laura A Cassiday; L James Maher
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

Review 5.  Biological functions of p53 isoforms through evolution: lessons from animal and cellular models.

Authors:  V Marcel; M-L Dichtel-Danjoy; C Sagne; H Hafsi; D Ma; S Ortiz-Cuaran; M Olivier; J Hall; B Mollereau; P Hainaut; J-C Bourdon
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

6.  Inherited germline TP53 mutation encodes a protein with an aberrant C-terminal motif in a case of pediatric adrenocortical tumor.

Authors:  Emilia M Pinto; Raul C Ribeiro; Gad B Kletter; John P Lawrence; Jesse J Jenkins; Jinling Wang; Sheila Shurtleff; Lisa McGregor; Richard W Kriwacki; Gerard P Zambetti
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

7.  Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (SARS) coronavirus infection of Vero cells.

Authors:  W F Leong; H C Tan; E E Ooi; D R Koh; Vincent T K Chow
Journal:  Microbes Infect       Date:  2005-01-22       Impact factor: 2.700

8.  Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection.

Authors:  Wai Fook Leong; Vincent T K Chow
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

9.  Changes in the expression of splicing factor transcripts and variations in alternative splicing are associated with lifespan in mice and humans.

Authors:  Benjamin P Lee; Luke C Pilling; Florence Emond; Kevin Flurkey; David E Harrison; Rong Yuan; Luanne L Peters; George A Kuchel; Luigi Ferrucci; David Melzer; Lorna W Harries
Journal:  Aging Cell       Date:  2016-06-30       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.